Patients
2.8 per 100,000 people
Suicide rate, Philippines, 2023 (WHO).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Chandani Patel
Philippines Pharmacogenomic Testing for Psychiatry Market Industry Trends and Forecast to 2034: Segmented by (Test, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$1.3 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $0.9 Mn | — | — |
| 2025 (base) | $1.0 Mn | +$0.1 Mn | — |
| 2026 (forecast) | $1.1 Mn | +$0.1 Mn | +10.1% |
| 2027 (forecast) | $1.2 Mn | +$0.1 Mn | +21.2% |
| 2028 (forecast) | $1.3 Mn | +$0.1 Mn | +33.5% |
| 2029 (forecast) | $1.4 Mn | +$0.1 Mn | +46.9% |
| 2030 (forecast) | $1.6 Mn | +$0.1 Mn | +61.8% |
| 2031 (forecast) | $1.7 Mn | +$0.2 Mn | +78.1% |
| 2032 (forecast) | $1.9 Mn | +$0.2 Mn | +96.1% |
| 2033 (forecast) | $2.1 Mn | +$0.2 Mn | +115.9% |
| 2034 (forecast) | $2.3 Mn | +$0.2 Mn | +137.7% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.0 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $2.3 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 10.1% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Test, application and end user (see all) |
| Key players | Myriad Genetics, Inc., Genomind, OneOme, Tempus, Thermo Fisher Scientific Inc. (see all) |
| Regulator in the Philippines | FDA PhilippinesSource: Food and Drug Administration Philippines. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Pharmacogenomic tests for psychiatry look at a person's genes to help doctors choose antidepressants and other mental health medicines that are likely to work.
Key segments of the pharmacogenomic Testing for Psychiatry market include test (Multi-Gene Panels and Single-Gene Tests) and application (Depression, Anxiety and ADHD).
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the pharmacogenomic Testing for Psychiatry market. Governments and employers are investing more in mental health care.
Digital tools, new drug classes and care built into primary care and workplaces give the pharmacogenomic Testing for Psychiatry market strong room to grow worldwide.
Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the pharmacogenomic Testing for Psychiatry market.
The pharmacogenomic Testing for Psychiatry market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices need registration or notification with the Food and Drug Administration of the Philippines (FDA).[1] PhilHealth is the national health insurer, and the Universal Health Care Act of 2019 makes every Filipino a member.[2] Suicide rate: 2.8 per 100,000 people in 2023, the latest WHO figure for the Philippines.[3]
[1] Food and Drug Administration Philippines. Checked 14 Nov 2026.
[2] PhilHealth. Checked 14 Nov 2026.
[3] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 15 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how pharmacogenomic Testing for Psychiatry products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Philippines.
What doctors and scientists are doing in Pharmacogenomic Testing for Psychiatry right now, from free public sources.
2.8 per 100,000 people
Suicide rate, Philippines, 2023 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 17 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.
From our blog
Philippines · 2 shared keywords
Philippines · 1 shared keyword
Philippines · 1 shared keyword
Philippines
Philippines
Philippines
Pharmaceuticals · Philippines
OTC & Nutraceuticals · Philippines
Pharmaceuticals · Philippines
Digital Health · Philippines
Digital Health · Philippines
Digital Health · Philippines